Postnatal brain and skull growth in an Apert syndrome mouse model

American Journal of Medical Genetics, Part A

Volumn 161, Issue 4, 2013, Pages 745-757

  Hill, Cheryl A ^a,b   Martínez Abadías, Neus ^c,d   Motch, Susan M ^c   Austin, Jordan R ^a   Wang, Yingli ^e   Jabs, Ethylin Wang ^e   Richtsmeier, Joan T ^c   Aldridge, Kristina ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Apert syndrome; Brain; Craniosynostosis; Development; Fibroblast growth factor receptor 2; Mouse; Skull; Suture

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ACROCEPHALOSYNDACTYLY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; BRAIN DEVELOPMENT; BRAIN REGION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FGFR2 GENE; GENE; GENE MUTATION; MOUSE; MUTATIONAL ANALYSIS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SKULL DEVELOPMENT; THREE DIMENSIONAL IMAGING; TISSUE CHARACTERIZATION; TISSUE INTERACTION;

ACROCEPHALOSYNDACTYLIA; ANIMALS; ANTHROPOMETRY; BRAIN; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MUTATION; ORGAN SIZE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; SKULL; TOMOGRAPHY, X-RAY COMPUTED;

MUS;

EID: 84875532639     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35805     Document Type: Article

References (65)

1. Aldridge K, Marsh JL, Govier D, Richtsmeier JT. 2002. Central nervous system phenotypes in craniosynostosis. J Anat 201:31-39.
2. Aldridge K, Reeves RH, Olson LE, Richtsmeier JT. 2007. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet Part A 143A:1060-1070.
3. Aldridge K, Hill CA, Austin JR, Percival C, Martínez-Abadías N, Neuberger T, Wang Y, Jabs EW, Richtsmeier JT. 2010. Brain phenotypes in two FGFR2 mouse models for Apert syndrome. Dev Dyn 239:987-997.
4. Anderson P, Netherway D, Abbott A, Cox T, Roscioli T, David D. 2004. Analysis of intracranial volume in Apert syndrome genotypes. Pediatr Neurosurg 40:161-164.
5. Bansal R, Lakhina V, Remedios R, Tole S. 2003. Expression of FGF receptors 1, 2, 3 in the embryonic and postnatal mouse brain compared with Pdgfra, Olig2 and Plp/dm20: Impliations for oligodendrocyte development. Dev Neurosci 25:83-95.
6. Chen L, Li D, Li C, Engel A, Deng C. 2003. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33:169-178.
7. Cheverud JM. 1982. Phenotypic, genetic, and environmental integration in the cranium. Evolution 36:499-516.
8. Cheverud JM. 1989. A comparative analysis of morphological variation patterns in the papionins. Evolution 43:1737-1747.
9. Cheverud JM. 1995. Morphological integration in the saddle-back tamarin (Saguinus fuscicollis) cranium. Am Nat 145:63-89.
10. Cohen MM. 2000. Apert syndrome. In: Cohen M, MacLean R, editors. Craniosynostosis: Diagnosis, evaluation, and management. New York: Oxford University Press. pp 316-353.
11. Cohen MM, Kreiborg S. 1990. The central nervous system in the Apert syndrome. Am J Med Genet 35:36-45.
12. Cohen MM, Kreiborg S. 1991. Agenesis of the corpus callosum. Its associated anomalies and syndromes with special reference to the Apert syndrome. Neurosurg Clin N Am 2:565-568.
13. Cohen MM Jr, Kreiborg S. 1993a. Growth pattern in the Apert syndrome. Am J Med Genet 47:617-623.
14. Cohen MM, Kreiborg S. 1993b. An updated pediatric perspective on the Apert syndrome. AJDC 147:989-993.
15. Cohen MM, Kreiborg S. 1994. Cranial size and configuration in the Apert syndrome. J Craniofac Genet Dev Biol 14:153-162.
16. Cohen MM Jr, Kreiborg S. 1996. Suture formation, premature sutural fusion, and suture default zones in Apert syndrome. Am J Med Genet 62:339-344.
17. Cohen MM, Kreiborg S, Lammer EJ, Cordero JF, Mastroiacovo P, Erickson JD, Roeper P, Martinez-Frias ML. 1992. Birth prevalence study of the Apert syndrome. Am J Med Genet 42:655-659.
18. Darroch JN, Mosimann JE. 1985. Canonical and principal components of shape. Biometrika 72:241-252.
19. de Leon GA, de Leon G, Grover WD, Zaeri N, Alburger PD. 1987. Agenesis of the corpus callosum and limbic malformation in Apert syndrome (type I acrocephalosyndactyly). Arch Neurol 44:979-982.
20. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P. 2002. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129:3783-3793.
21. Ever L, Zhao R, Eswarakumar VP, Gaiano N. 2008. Fibroblast growth factor receptor 2 plays an essential role in telencephalic progenitors. Dev Neurosci 30:306-318.
22. Falsetti AB, Jungers WL, Cole TM. 1993. Morphometrics of the callitrichid forelimb: A case study in size and shape. Inter J Primat 14:551-572.
23. Gosain A, McCarthy J, Glatt P, Staffenberg D, Hoffmann R. 1995. A study of intracranial volume in Apert syndrome. Plast Reconstr Surg 95:284-295.
24. Hajihosseini M. 2008. Fibroblast growth factor signaling in cranial suture development and pathogenesis. In: Rice D, editor. Craniofacial sutures development, disease and treatment. Basel: Karger. pp 160-177.
25. Hallgrímsson B, Willmore K, Dorval C, Cooper DM. 2004. Craniofacial variability and modularity in macaques and mice. J Exp Zool B Mol Dev Evol 302:207-225.
26. Hallgrímsson B, Lieberman DE, Young NM, Parsons TE, Wat S. 2007. Evolution of covariance in the mammalian skull. Novartis Found Symp 284:164-185.
27. Hatch NE. 2010. FGF signaling in craniofacial biological control and pathological craniofacial development. Crit Rev Eukaryot Gene Expr 20:295-311.
28. Hill CA, Reeves RH, Richtsmeier JT. 2007. Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat 210:394-405.
29. Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. 2001. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci USA 98:7182-7187.
30. Jamniczky HA, Hallgrímsson B. 2011. Modularity in the skull and cranial vasculature of laboratory mice: Implications for the evolution of complex phenotypes. Evol Dev 13:28-37.
31. Jungers WL, Falsetti AB, Wall CE. 1995. Shape, relative size, and size-adjustments in morphometrics. Yearbook Phys Anthropol 38:137-161.
32. Karaplis AC. 2008. Embryonic development of bone and regulation of intramembranous and endochondral bone formation. In: Bilezikian JP, Raisz LG, Martin TJ, editors. Principles of bone biology, 3rd edition. Burlington: Academic Press. pp 53-84.
33. Kobayashi T. 1963. Brain-to-body ratios and time of maturation of the mouse brain. Am J Physiol 204:343-346.
34. Kreiborg S, Cohen MM Jr. 1990. Characteristics of the infant Apert skull and its subsequent development. J Craniofac Genet Dev Biol 10:399-410.
35. Lele S, Richtsmeier JT. 2001. An invariant approach to the statistical analysis of shapes. London: Chapman and Hall/CRC Press.
36. Mao JJ, Wang X, Mooney MP, Kopher RA, Nudera JA. 2003. Strain induced osteogenesis of the craniofacial suture upon controlled delivery of low-frequency cyclic forces. Front Biosci 8:a10-a17.
37. Marcucio RS, Young NM, Hu D, Hallgrimsson B. 2011. Mechanisms that underlie co-variation of the brain and face. Genesis 49:177-189.
38. Maric D, Fiorio Pla A, Chang YH, Barker JL. 2007. Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signagling via specific FGF receptors. J Neurosci 27:1836-1852.
39. Marsh JL, Galic M, Vannier MW. 1991. The craniofacial anatomy of Apert syndrome. Clin Plast Surg 18:237-249.
40. Martínez-Abadías N, Percival C, Aldridge K, Hill CA, Sirivunnabood S, Wang Y, Jabs EW, Richstmeier JT. 2010. Variation in skull phenotypes of Fgfr2 mouse models for Apert syndrome. Dev Dyn 239:3058-3071.
41. Martínez-Abadías N, Heuzé Y, Wang Y, Jabs EW, Aldridge K, Richtsmeier JT. 2011. FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: Evidence from Apert syndrome mouse models. PLoS ONE 6:e26425.
42. Merrill AE, Bochukova EG, Brugger SM, Ishii M, Pilz DT, Wall SA, Lyons KM, Wilkie AO, Maxson RE Jr. 2006. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet 15:1319-1328.
43. Noden DM, Trainor PA. 2005. Relations and interactions between cranial mesoderm and neural crest populations. J Anat 207:575-601.
44. Opperman LA. 2000. Cranial sutures as intramembranous bone growth sites. Dev Dyn 219:472-485.
45. Park W-J, Theda C, Maestri NE, Meyers GA, Fryburg JS, Dufresne C, Cohen MM, Jabs EW. 1995. Analysis of phenotypic features of FGFR2 mutations in Apert syndrome. Am J Hum Genet 57:321-328.
46. Parsons TE, Schmidt EJ, Boughner JC, Jamniczky HA, Marcucio RS, Hallgrimsson B. 2011. Epigenetic integration of the developing brain and face. Dev Dyn 240:2233-2244.
47. Pooh R, Nakagawa Y, Pooh K, Nakagawa Y, Nagamachi N. 1999. Fetal craniofacial structure and intracranial morphology in a case of Apert syndrome. Ultrasound Obstet Gynecol 13:274-280.
48. Posnick J, Armstrong D, Bite U. 1995. Crouzon and Apert syndromes: Intracranial volume measurements before and after cranio-orbital reshaping in childhood. Plast Reconstr Surg 96:539-548.
49. Renier D, Lajeunie E, Arnaud E, Marchac D. 2000. Management of craniosynostoses. Childs Nerv Syst 16:645-658.
50. Richtsmeier JT. 1988. Craniofacial growth in Apert syndrome as measured by finite-element scaling analysis. Acta Anat (Basel) 133:50-56.
51. Richtsmeier JT, Lele S. 1993. A coordinate-free approach to the analysis of growth patterns: Models and theoretical considerations. Biol Rev Camb Philos Soc 68:381-411.
52. Richtsmeier JT, Corner BD, Grausz HM, Cheverud JM, Danahey SM. 1993. The role of postnatal growth pattern in the production of facial morphology. Syst Biol 42:307-330.
53. Richtsmeier JT, Paik C, Elfert P, Cole TM, Dahlman H. 1995. Precision, repeatability and validation of the localization of cranial landmarks using computed tomography scans. Cleft Palate Craniofac J 32:217-227.
54. Richtsmeier JT, Cole TM, Krovitz G, Valeri CJ, Lele S. 1998. Preoperative morphology and development in sagittal synostosis. J Craniofac Genet Dev Biol 18:64-78.
55. Richtsmeier JT, DeLeon VB, Lele SR. 2002. The promise of geometric morphometrics. Am J Phys Anthropol Suppl 35:63-91.
56. Richtsmeier JT, Aldridge K, DeLeon VB, Panchal J, Kane AA, Marsh JL, Yan P, Cole TM. 2006. Phenotypic integration of neurocranium and brain. J Exp Zool B Mol Dev Evol 306:360-378.
57. Tokumaru A, Barkovich A, Ciricillo S, Edwards M. 1996. Skull base and calvarial deformities: Association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol 17:619-630.
58. von Gernet S, Golla A, Ehrensfels Y, Schuffenhauer S, Fairley JD. 2000. Genotype-phenotype analysis in Apert syndrome suggests opposite effects of the two recurrent mutations on syndactyly and outcome of craniofacial surgery. Clin Genet 57:137-139.
59. Wang Y, Sun M, Uhlhorn V, Peter I, Hill CA, Percival CJ, Richtsmeier JT, Huso DL, Jabs EW. 2010. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2+/P253R mice. BMC Dev Biol 10:22.
60. Wilke TA, Gubbels S, Schwartz J, Richman JM. 1997. Expression of fibroblast growth factor receptors (FGFR1, FGFR2, FGFR3) in the developing head and face. Dev Dyn 210:41-52.
61. Wilkie AO, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9:165-172.
62. Yacubian-Fernandes A, Palhares A, Giglio A, Gabarra R, Zanini S, Portela L, Plese JP. 2004. Apert syndrome: Analysis of associated brain malformations and conformational changes determined by surgical treatment. J Neuroradiol 31:116-122.
63. Yoon K, Nery S, Rutlin ML, Radtke F, Fishell G, Gaiano N. 2004. Fibroblast growth factor receptor signaling promotes radial glial identity and interacts with Notch1 signaling in telencephalic progenitors. J Neurosci 24:9497-9506.
64. Yu K, Herr AB, Waksman G, Ornitz DM. 2000. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 97:14536-14541.
65. Yu K, Ornitz DM. 2001. Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes. Proc Natl Acad Sci USA 98:3641-3643.